1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cleanroom airborne particulate limits and 70% isopropyl alcohol: a lingering problem for pharmaceutical manufacturing?

      1
      PDA journal of pharmaceutical science and technology

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Seventy percent isopropyl alcohol (70% IPA) in water for injection is extensively utilised within pharmaceutical cleanrooms for glove and surface disinfection. When supplied in pressurised containers and delivered as an aerosol, it has been demonstrated that large quantities of 70% IPA particles are generated that remain airborne for substantial periods of time. Within non-unidirectional airflow cleanroom areas, such particles are likely to be recorded by the particle monitoring system. Consequently, the derived operational limits for particles will almost certainly be at "artificially high" levels and any particle generating activities with contamination potential may be masked. These high particle levels may not comply with the requirements of Annex 1 of the European Unions Guide to Good Manufacturing Practices (EU GGMP) and the United States Food and Drug Administration (FDA) Aseptic Processing Guideline. This is the case predominantly for the larger particles (> or =5 microm), the monitoring of which is exclusively required by the Annex 1 guide. However, by using canisters that deliver the 70% IPA as a stream, large quantities of particles are not generated and more meaningful and compliant operational levels can be obtained. Additionally, the EU GGMP's Annex 1 continuing requirement to monitor particles > or =5 microm appears to have little value or scientific justification and restricts further harmonisation of the European guide with the US FDA Aseptic Processing Guideline.

          Related collections

          Author and article information

          Journal
          PDA J Pharm Sci Technol
          PDA journal of pharmaceutical science and technology
          1079-7440
          1079-7440
          February 23 2010
          : 63
          : 6
          Affiliations
          [1 ] AstraZeneca, UK Operations, Macclesfield, Cheshire, England. tim.eaton@astrazeneca.com
          Article
          20169862
          9681505d-c15f-4c08-a9c4-d69128a2d4a5
          History

          Comments

          Comment on this article